These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 4385710)

  • 1. Deficiency of pneumococcal serum opsonizing activity in sickle-cell disease.
    Winkelstein JA; Drachman RH
    N Engl J Med; 1968 Aug; 279(9):459-66. PubMed ID: 4385710
    [No Abstract]   [Full Text] [Related]  

  • 2. An abnormality of the alternate pathway of complement activation in sickle-cell disease.
    Johnston RB; Newman SL; Struth AG
    N Engl J Med; 1973 Apr; 288(16):803-8. PubMed ID: 4144343
    [No Abstract]   [Full Text] [Related]  

  • 3. Opsonins: their function, identity, and clinical significance.
    Winkelstein JA
    J Pediatr; 1973 May; 82(5):747-53. PubMed ID: 4144636
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum opsonization of salmonella in sickle cell anemia.
    Hand WL; King NL
    Am J Med; 1978 Mar; 64(3):388-95. PubMed ID: 345801
    [No Abstract]   [Full Text] [Related]  

  • 5. Sickle-cell disease and the properdin system.
    Rosen FS
    N Engl J Med; 1973 Apr; 288(16):845-6. PubMed ID: 4144345
    [No Abstract]   [Full Text] [Related]  

  • 6. Relation between serum opsonic activity for Streptococcus pneumoniae and complement function in sickle cell disease.
    Bjornson AB; Lobel JS; Harr KS
    J Infect Dis; 1985 Oct; 152(4):701-9. PubMed ID: 3930618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral components of host defense in sickle cell disease during painful crisis and asymptomatic periods.
    Bjornson AB; Lobel JS; Lampkin BC
    J Pediatr; 1980 Feb; 96(2):259-62. PubMed ID: 7351591
    [No Abstract]   [Full Text] [Related]  

  • 8. Pneumococcal serum opsonizing activity in splenectomized children.
    Winkelstein JA; Lambert GH; Swift A
    J Pediatr; 1975 Sep; 87(3):430-3. PubMed ID: 240922
    [No Abstract]   [Full Text] [Related]  

  • 9. Decreased opsonization for Streptococcus pneumoniae in sickle cell disease: studies on selected complement components and immunoglobulins.
    Bjornson AB; Gaston MH; Zellner CL
    J Pediatr; 1977 Sep; 91(3):371-8. PubMed ID: 19568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opsonization of pneumococci by whole serum from sickle cell disease patients.
    Bloch EF; Castro O; Gregory JE; Okoh C
    J Natl Med Assoc; 1984 Feb; 76(2):179-82. PubMed ID: 6708126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration by normal human immunoglobulin G of deficient serum opsonization for Streptococcus pneumoniae in sickle cell disease.
    Bjornson AB; Lobel JS; Magnafichi PI; Lampkin BC
    Infect Immun; 1981 Aug; 33(2):636-40. PubMed ID: 7275323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of serum opsonins with in vitro phagocytosis of Streptococcus pneumoniae.
    Chudwin DS; Artrip SG; Korenblit A; Schiffman G; Rao S
    Infect Immun; 1985 Oct; 50(1):213-7. PubMed ID: 4044034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct evidence that decreased serum opsonization of Streptococcus pneumoniae via the alternative complement pathway in sickle cell disease is related to antibody deficiency.
    Bjornson AB; Lobel JS
    J Clin Invest; 1987 Feb; 79(2):388-98. PubMed ID: 3805275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased susceptibility to infection in sickle cell disease: defects of opsonization and of splenic function.
    Johnston RB; Newman SL; Struth AG
    Birth Defects Orig Artic Ser; 1975; 11(1):322-7. PubMed ID: 238677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sickle cell anemia and severe infections due to encapsulated bacteria.
    Pearson HA
    J Infect Dis; 1977 Aug; 136 Suppl():S25-30. PubMed ID: 330779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of a requirement for the Fc region of IgG in restoring pneumococcal opsonization via the alternative complement pathway in sickle cell disease.
    Bjornson AB; Lobel JS
    J Infect Dis; 1986 Nov; 154(5):760-9. PubMed ID: 3095435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum opsonic activity and antibody concentration in patients with sickle cell disease after pneumococcal polysaccharide immunization.
    Chudwin DS; Wara DW; Matthay KK; Caulfield MH; Schiffmann G; Mentzer WC; Ammann AJ
    J Pediatr; 1983 Jan; 102(1):51-4. PubMed ID: 6848728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective yeast opsonisation and functional deficiency of complement in sickle cell disease.
    Larcher VF; Wyke RJ; Davis LR; Stroud CE; Williams R
    Arch Dis Child; 1982 May; 57(5):343-6. PubMed ID: 7092289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opsonizing factors in human serum. 3. Phagocytosis of Salmonella typhimurium.
    Slopek S; Grzybek-Hryncewicz K; Ladosz J; Kubis-Parusel K
    Arch Immunol Ther Exp (Warsz); 1967; 15(1):26-33. PubMed ID: 4860418
    [No Abstract]   [Full Text] [Related]  

  • 20. Opsonization of pneumococci. I. Heat-labile serum activity other than complement is required for killing by human polymorphonuclear leukocytes.
    Guckian JC; Christensen GD; Schweinle JE; Fine DP
    J Immunol; 1981 Oct; 127(4):1659-65. PubMed ID: 7276577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.